BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30888678)

  • 1. Clinicopathologic Features and Surgical Outcomes of Neuroendocrine Carcinoma of the Gallbladder.
    Tanioka N; Okabayashi T; Sui K; Matsumoto T; Iwata J; Morita S; Shimada Y
    Surg Technol Int; 2019 May; 34():101-106. PubMed ID: 30888678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma.
    Chen C; Wang L; Liu X; Zhang G; Zhao Y; Geng Z
    Int J Clin Exp Pathol; 2015; 8(7):8218-26. PubMed ID: 26339390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder.
    Yun SP; Shin N; Seo HI
    World J Gastroenterol; 2015 Jan; 21(1):269-75. PubMed ID: 25574101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of neuroendocrine carcinoma in the hepatic hilar lymph nodes concomitant with an adenocarcinoma of the gallbladder.
    Okada H; Uchida Y; Matsuzaki N; Goto T; Nishimura S; Kurita A; Nishimura T; Yazumi S; Terajima H
    World J Surg Oncol; 2016 Nov; 14(1):284. PubMed ID: 27842605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine carcinoma of gallbladder: a case series and literature review.
    Liu W; Chen W; Chen J; Hong T; Li B; Qu Q; He X
    Eur J Med Res; 2019 Feb; 24(1):8. PubMed ID: 30717775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Pure" large cell neuroendocrine carcinoma of the gallbladder. Report of a case and review of the literature.
    Buscemi S; Orlando E; Damiano G; Portelli F; Palumbo VD; Valentino A; Marrazzo A; Buscemi G; Lo Monte AI
    Int J Surg; 2016 Apr; 28 Suppl 1():S128-32. PubMed ID: 26708705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
    Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
    J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
    Feng M; Zou J; Zhang Y; Sun L
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinicopathological characteristics and prognostic factors of patients with primary gallbladder neuroendocrine carcinomas.
    Wang W; Yang CX; Yu XZ; Zhang SL; Wang J; Wang J
    J Dig Dis; 2022 Mar; 23(3):166-173. PubMed ID: 35187836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the relationships between clinicopathologic factors and survival in gallbladder cancer following surgical resection with curative intent.
    Yang XW; Yang J; Li L; Man XB; Zhang BH; Shen F; Wu MC
    PLoS One; 2012; 7(12):e51513. PubMed ID: 23300551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion surgery after extensive chemotherapy for stage IV mixed adenoneuroendocrine carcinoma (MANEC) of the gallbladder: clinical implications from the patterns of response and recurrence.
    Kamei K; Shindoh J; Kiya Y; Matsumoto I; Hashimoto M; Takeyama Y
    Clin J Gastroenterol; 2020 Apr; 13(2):240-246. PubMed ID: 31617127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma.
    Aramaki M; Matsumoto T; Shibata K; Himeno Y; Yada K; Hirano S; Sasaki A; Kawano K; Kitano S
    Hepatogastroenterology; 2004; 51(60):1609-11. PubMed ID: 15532788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fourteen year surgical experience of gallbladder cancer: validity of curative resection affecting survival.
    Choi SB; Han HJ; Kim CY; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
    Hepatogastroenterology; 2012; 59(113):36-41. PubMed ID: 22251521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study.
    Lee W; Jeong CY; Jang JY; Kim YH; Roh YH; Kim KW; Kang SH; Yoon MH; Seo HI; Yun SP; Park JI; Jung BH; Shin DH; Choi YI; Moon HH; Chu CW; Ryu JH; Yang K; Park YM; Hong SC
    Surgery; 2017 Sep; 162(3):515-524. PubMed ID: 28629653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes and Prognostic Factors in Advanced Gallbladder Cancer: Focus on the Advanced T Stage.
    Chen C; Geng Z; Shen H; Song H; Zhao Y; Zhang G; Li W; Ma L; Wang L
    PLoS One; 2016; 11(11):e0166361. PubMed ID: 27846279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-specific clinicopathological characteristics and prognostic analysis of neuroendocrine carcinomas of the gallbladder.
    Zhang Z; Guo T; Huang X; Xie P; Wang L; Yu Y
    Cancer Med; 2022 Feb; 11(3):641-653. PubMed ID: 34841738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and outcomes analysis of Gallbladder neuroendocrine carcinoma.
    Jiang M; Zhang Y
    J Cancer Res Ther; 2023 Aug; 19(4):910-916. PubMed ID: 37675716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic heterogeneity of the seventh edition of UICC Stage III gallbladder carcinoma: Which patients benefit from surgical resection?
    Sakata J; Kobayashi T; Ohashi T; Hirose Y; Takano K; Takizawa K; Miura K; Ishikawa H; Toge K; Yuza K; Soma D; Ando T; Wakai T
    Eur J Surg Oncol; 2017 Apr; 43(4):780-787. PubMed ID: 28132788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare case of a gallbladder neuroendocrine carcinoma.
    Fujii M; Saito H; Shiode J
    Clin J Gastroenterol; 2019 Feb; 12(1):38-45. PubMed ID: 30003469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cases of neuroendocrine carcinoma of the gallbladder.
    Chen H; Shen YY; Ni XZ
    World J Gastroenterol; 2014 Sep; 20(33):11916-20. PubMed ID: 25206300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.